Sunshine Biopharma Inc. (SBFMW) Revenue 2017–2025
Sunshine Biopharma Inc. (SBFMW) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$36.3MFY2025 · since FY2017: $0 → $36.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $36.3M | +4.1% |
| FY2024 | $34.9M | +44.7% |
| FY2023 | $24.1M | +454.4% |
| FY2022 | $4.3M | +1802.4% |
| FY2021 | $228,426 | +219.9% |
| FY2020 | $71,410 | +238.1% |
| FY2019 | $21,121 | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW Net incomeSBFMW Net marginSBFMW Gross profitSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →